PathoQuest achieves Illumina Propel Certification

PathoQuest is pleased to announce that it has received Propel Certification from Illumina after successfully completing the requirements for achieving this recognition. This included demonstrating the ability to produce high-quality data on the NexSeq System following...

PathoQuest nominated for a 2018 PrixGalien MedStartup award

PathoQuest has been nominated for a 2018 PrixGalien MedStartup award, an initiative between The Galien Foundation and Business France to encourage and reward international partnerships between French and North American innovators in the Life Sciences Industry....

PathoQuest to attend 36th Annual JP Morgan Healthcare Conference

PathoQuest will be in attendance at 36th Annual JP Morgan Healthcare Conference being held in San Francisco on January 8 - 11, 2018. The J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry which brings...